Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 38.60
+0.60 (1.58%)
Jul 15, 2026, 4:25 PM CET
Gentian Diagnostics ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 587 | 870 | 605 | 640 | 632 | 1,110 | |
Market Cap Growth | -39.73% | 43.88% | -5.54% | 1.22% | -43.06% | 32.20% |
Enterprise Value | 524.9 | 786.86 | 529.84 | 565.44 | 566.04 | 1,014 |
Last Close Price | 38.60 | 56.40 | 39.20 | 41.50 | 41.00 | 72.00 |
PE Ratio | - | 65.58 | 13.66 | - | - | - |
Forward PE | 26.03 | 29.00 | 28.52 | - | - | - |
PS Ratio | 3.23 | 4.93 | 3.98 | 4.74 | 5.65 | 11.10 |
PB Ratio | 3.22 | 4.24 | 3.12 | 4.36 | 4.10 | 6.35 |
P/TBV Ratio | 3.35 | 5.17 | 3.73 | 5.10 | 5.27 | 7.77 |
P/FCF Ratio | 32.15 | 21.02 | 50.04 | 44.13 | - | - |
P/OCF Ratio | 30.47 | 20.42 | 44.92 | 41.40 | - | - |
EV/Sales Ratio | 2.88 | 4.46 | 3.48 | 4.18 | 5.06 | 10.14 |
EV/EBITDA Ratio | 17.63 | 22.76 | 21.46 | - | - | - |
EV/EBIT Ratio | 22.92 | 30.92 | 33.70 | - | - | - |
EV/FCF Ratio | 28.73 | 19.01 | 43.86 | 38.99 | - | - |
Debt / Equity Ratio | 0.09 | 0.09 | 0.03 | 0.06 | 0.08 | 0.08 |
Debt / EBITDA Ratio | 9.85 | 0.67 | 0.41 | - | - | - |
Debt / FCF Ratio | 0.92 | 0.56 | 0.83 | 0.90 | - | - |
Net Debt / Equity Ratio | -0.34 | -0.40 | -0.38 | -0.51 | -0.43 | -0.55 |
Net Debt / EBITDA Ratio | -36.63 | -2.40 | -3.03 | 23.34 | 5.10 | 6.22 |
Net Debt / FCF Ratio | -3.42 | -2.00 | -6.18 | -5.14 | 2.93 | 3.43 |
Asset Turnover | 0.76 | 0.72 | 0.74 | 0.73 | 0.56 | 0.45 |
Inventory Turnover | 1.51 | 1.56 | 1.67 | 1.87 | 1.54 | 1.70 |
Quick Ratio | 5.20 | 3.81 | 3.85 | 4.13 | 4.58 | 6.10 |
Current Ratio | 7.43 | 5.40 | 5.38 | 5.60 | 6.33 | 7.42 |
Return on Equity (ROE) | -4.34% | 6.64% | 26.59% | -7.08% | -14.36% | -13.43% |
Return on Assets (ROA) | -5.10% | 5.39% | 17.28% | -7.11% | -11.63% | -10.22% |
Return on Invested Capital (ROIC) | -10.64% | 10.89% | 37.09% | -16.39% | -27.94% | -33.28% |
Return on Capital Employed (ROCE) | -3.46% | 12.01% | 8.85% | -7.94% | -13.09% | -11.37% |
Earnings Yield | - | 1.52% | 7.32% | - | - | - |
FCF Yield | 3.11% | 4.76% | 2.00% | 2.27% | - | - |
Dividend Yield | 1.58% | 0.71% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | - | 46.54% | 0.00% | 0.00% | 0.00% | 0.00% |
Buyback Yield / Dilution | 3.33% | 1.73% | -2.20% | 5.87% | -1.41% | -0.97% |
Total Shareholder Return | 4.90% | 2.44% | -2.20% | 5.87% | -1.41% | -0.97% |